Multiple nucleic acids testing on a low-cost digital microfluidic platform for respiratory bacteria (MNAT-DMF)

Area of Science:

• Biomedical Engineering
• Molecular Diagnostics
• Microfluidics

Background:

• Lower respiratory tract bacterial infections pose a significant global health challenge.
• Current diagnostic methods often lack the speed and accuracy needed for timely intervention.
• Distinguishing between various bacterial pathogens with similar symptoms is difficult.

Purpose of the Study:

• To develop a rapid, accurate, and integrated diagnostic platform for identifying key respiratory bacterial pathogens.
• To utilize a digital microfluidic chip for simultaneous detection of multiple bacteria.
• To create a cost-effective and automated solution for point-of-care diagnostics.

Main Methods:

• Integration of DNA extraction, isothermal amplification, and CRISPR-based detection on a digital microfluidic chip.
• Utilized voltage-controlled droplet movement for automated sample handling.
• Performed assays at a constant temperature of 37°C, eliminating thermal cycling.

Main Results:

• Successfully detected six types of respiratory pathogenic bacteria within one hour.
• Demonstrated high clinical sensitivity and specificity.
• The system operated efficiently at 37°C without bulky equipment.

Conclusions:

• The digital microfluidic chip platform offers a promising approach for rapid, automated, and cost-effective diagnosis of respiratory bacterial infections.
• This technology can significantly improve the speed and accuracy of pathogen identification in clinical settings.
• The integrated system simplifies complex molecular diagnostic procedures for broader accessibility.